RxDoctor Payments Data

Leah Smith, MD

Internal Medicine · Jackson, MSNPI 1841630076

Payments from drug & device makers

$749in general payments, 2019–2025

Across 45 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$195
  • Novo Nordisk$187
  • Boehringer Ingelheim$123
  • Lilly USA, LLC$89
  • Gilead$38
  • Sanofi-aventis U.S. LLC$33
  • plus $85 from 4 others

What the payments were for

  • Food & beverage$749100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$749 in reported general payments places this provider in the 55th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$1,263
Medicare patients
26
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin53$76,429
EliquisApixaban42$52,927
OzempicSemaglutide31$35,779
JanuviaSitagliptin Phosphate22$34,156
TrulicityDulaglutide16$29,296
RybelsusSemaglutide13$26,770
TradjentaLinagliptin27$23,840
FarxigaDapagliflozin Propanediol23$23,282
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$19,767
Janumet XrSitagliptin Phos/Metformin Hcl13$15,103
SymbicortBudesonide/Formoterol Fumarate25$8,701
Tresiba Flextouch U-100Insulin Degludec12$7,009
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$6,682
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$5,091
Novolog FlexpenInsulin Aspart20$4,053

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$123$100,26980 claims
Novo NordiskOzempic, Rybelsus$187$62,54944 claims
PfizerEliquis$11$52,92742 claims
MerckJanuvia, Janumet Xr$195$49,25835 claims
AstraZenecaFarxiga, Symbicort$15$31,98348 claims
Lilly USA, LLCTrulicity$89$29,29616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →